Manufacturers Life Insurance Company, The Vista Gen Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 11, 2023	SELL	$0.14 - $4.8 $5,090 - $174,542	-36,363 Reduced 44.42%	45,494 $7,000
Q3 2022 Nov 03, 2022	SELL	$0.14 - $4.8 $5,090 - $174,542	-36,363 Reduced 44.42%	45,494 $7,000
Q2 2022 Aug 11, 2023	SELL	$0.88 - $1.73 $251 - $494	-286 Reduced 0.35%	81,857 $72,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $251 - $494	-286 Reduced 0.35%	81,857 $72,000
Q1 2022 Aug 11, 2023	BUY	$1.14 - $2.09 $93,643 - $171,678	82,143 New	82,143 $101,000
Q1 2022 May 20, 2022	SELL	$1.14 - $2.09 $26,232 - $48,092	-23,011 Reduced 21.88%	82,143 $102,000
Q4 2021 Feb 16, 2022	BUY	$1.67 - $2.76 $2,383 - $3,938	1,427 Added 1.38%	105,154 $205,000
Q3 2021 Nov 12, 2021	SELL	$2.62 - $3.45 $17,622 - $23,204	-6,726 Reduced 6.09%	103,727 $284,000
Q2 2021 Aug 12, 2021	BUY	$1.96 - $3.15 $216,487 - $347,926	110,453 New	110,453 $348,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.